Poulin, P., H. M. Jones, R. D. Jones, J. W. T. Yates, C. R. Gibson, J. Y. Chien, B. J. Ring, K. K. Adkison, H. He, R. Vuppugalla, P. Marathe, V. Fischer, S. Dutta, V. K. Sinha, T. Björnsson, T. Lavé, and M. S. Ku. 2011a. PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 1: Goals, properties of the PhRMA dataset, and comparison with literature datasets. Journal of Pharmaceutical Sciences 100: n/a. doi: 10.1002/jps.22554

Poulin, P., R. D. O. Jones, H. M. Jones, H. M. Gibson, M. Rowland, J. Y. Chien, B. J. Ring, K. K. Adkison, M. S. Ku, H. He, R. Vuppugalla, P. Marathe, V. Fischer, S. Dutta, V. K. Sinha, T. Björnsson, T. Lavé, and J. W. T. Yates. 2011b. PHRMA CPCDC initiative on predictive models of human pharmacokinetics, part 5: Prediction of plasma concentration–time profiles in human by using the physiologically-based pharmacokinetic modeling approach. Journal of Pharmaceutical Sciences 100: n/a. doi: 10.1002/jps.22550.

Querec, T. D., R. S. Akondy, E. K. Lee, W. Cao, H. I. Nakaya, D. Teuwen, A. Pirani, K. Gernert, J. Deng, B. Marzolf, K. Kennedy, H. Wu, S. Bennouna, H. Oluoch, J. Miller, R. Z. Vencio, M. Mulligan, A. Aderem, R. Ahmed, and B. Pulendran. 2009. Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans. Nature Immunology10(1):116-125.

Ring, B. J., J. Y. Chien, K. K. Adkison, H. M. Jones, M. Rowland, R. D. Jones, J. W. T. Yates, M. S. Ku, C. R. Gibson, H. He, R. Vuppugalla, P. Marathe, V. Fischer, S. Dutta, V. K. Sinha, T. Björnsson, T. Lavé, and P. Poulin. 2011. PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 3: Comparative assessement of prediction methods of human clearance. Journal of Pharmaceutical Sciences 100:n/a. doi: 10.1002/jps.22552.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement